Before fan idea forms, there is an abyss of chaotic thinking. A buzzing and swirling of insights trying to form into one cohesive way forward. Eventually, the chaos coalesces into an actionable idea. Which leads to industry. And ultimately, progress. Change for the better. Companies that make a difference.
We are the fuel for this process. Willing to invest before inception. Seeing things through to success. And we have no interest in merely talking about the future. We’re funding it.
We are the fuel for this process. Willing to invest before inception. Seeing things through to success. And we have no interest in merely talking about the future. We’re funding it.
Genius is an element that cannot be controlled. But to be successful, it requires guidance and a purpose. Because inherent in every spark is value. And the fuel to turn a spark into a raging fire is capital, experience and leadership. From the cutting-edge to the edge of the universe, you will find us. Chaotic Capital. Ensuring that intelligence operates independently, business is left to its own devices and the entrepreneurial spirit ascends with confidence into the marketplace.
Chaotic Capital is the result of a decades-long partnership between Ben Lamm and Andrew Busey - two tenured, successfull entrepreneurs and tech investors. Individually, they've led companies, authored books, registered patents, invented fundamental technologies and much more. But as both a founder and investment team, they have a reputation for success in growing companies from idea to acquisition
Creative technology studio focused on software, mobile development and design.
***
ACCENTURE NYSE: ACN
Immersive, digital gaming experiences.
***
Zynga NASDAQ: ZNGA
AI-driven, conversational intelligence.
***
LivePerson NASDAQ: LPSN
Enterprise AI solutions for space, critical infrastructure and defense.
***
Trive Capital
4D visualization, spatial mapping and sensory fusion.
A de-extinction and genomics technology company.
AI-powered data management platform for biotechnology, cell and gene therapy development.
